Curium Pharma
  • Home
  • About
    • Who we are
    • What we do
    • How we work
    • Worldwide offices
    • Management team
    • Sustainability
  • Products
    • European products
    • US products
    • Canadian products
    • Monrol products
    • Drug safety
  • Resources
    • Clinical Trials
    • Investigator Initiated Studies
    • Expanded Access
  • News
    • 30 Years in NETs
    • Press releases
    • Events
  • Careers
    • Current Listings
    • Application process
    • Working at Curium
    • Meet our people
    • Internships
  • Contact
enfrdeesnlit
Curium Pharma

Filter by

  • Press releases
  • Events
  • May 2025
  • April 2025
  • March 2025
  • January 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • May 2023
  • March 2023
  • December 2022
  • November 2022
  • August 2022
  • June 2022
  • May 2022
  • April 2022
  • January 2022
  • December 2021
  • October 2021
  • August 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • January 2021
  • December 2020
  • September 2020
  • June 2020
  • April 2020
  • March 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019
  • February 2019
  • January 2019
  • September 2018
  • August 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • September 2017
  • June 2017
  • April 2017
  • January 2017
  • August 2016
< Previous Back to news Next >
petten manufacturing site

5th February 2019

Curium Petten and NRG Agreement

A multi-year agreement between NRG and Curium has been signed for the production of Molybdenum-99, the base material for Technetium-99 (Tc 99m) generators. Tc 99m is the most important isotope used in nuclear medicine and is essential in the diagnosis of life-threatening diseases, such as cardiovascular, lung and brain diseases, as well as cancer.

  • About Curium
    • Who we are
    • What we do
    • How we work
    • Worldwide offices
    • Management team
    • ESG
  • Products
    • European products
    • US products
    • Canadian products
    • Drug safety
    • Online Ordering (Dublin, Ireland)
  • News
    • 30 Years in NETs
    • Press releases
    • Events
  • Resources
    • Education
    • Video & audio files
    • About Clinical Trials
  • Careers
    • Application process
    • Working at Curium
    • Meet our people
    • Internships
  • More
    • U.S. Ts&Cs of sale
    • Contact us
    • Terms of use
    • Privacy statement
    • Cookies policy
    • US Patents
Drug Distributor
LinkedIn Instagram X YouTube

Copyright © 2017-2025. Website content is subject to copyright protection. Please refer to Terms of Use for more information. For Cyber Security topics please contact the Cyber Security Team.

Website by Wani Creative